Interview with Robert J. Cipolle
2012-06-12
Loading...
View/Download File
Persistent link to this item
Statistics
View StatisticsJournal Title
Journal ISSN
Volume Title
Title
Interview with Robert J. Cipolle
Published Date
2012-06-12
Publisher
University of Minnesota
Type
Oral History
Abstract
Dr. Robert Cipolle begins his interview by briefly discusses his early life and education. He describes his time in the relatively new Pharm.D. at the University of Minnesota, his residency in Twin Cities area hospitals, and how the atmosphere of acceptance of the clinical pharmacy in Minnesota differed from areas. Dr. Cipolle then discusses the following topics regarding the changing culture surrounding pharmacy and pharmaceuticals: his move to University Hospital to support the growth of the clinical pharmacy program there; running the hospital pharmacy at Saint Paul-Ramsey; conflicts within the pharmacy therapeutics committee; equivalence, substitution, and prescriptive power issues in the 1970s, 1980s, and 1990s; the creation of the Peters Institute of Pharmaceutical Care; the practice of medication therapy management (MTM); the development of a billing system for clinical pharmacy; the training of clinical pharmacists as opposed to pharmacists working in dispensaries; and the introduction of the patient package insert. Following this discussion of larger trends, Dr. Cipolle reflects on his time in administration in the College of Pharmacy, including his time as associate dean under Gilbert Banker, changing the curriculum within the College, and his time as interim dean. He then describes the following: the relationship between the College and the Department of Pharmacology in the Medical School; the conversion to an all Pharm.D. program; the creation of the pharmacy program in Duluth; relations between the College and the basic sciences; failed discussions regarding the creation of a two-year pharmacy technician program; poison control and collaborations with the Medical and Nursing Schools; budget issues and long-range planning; funding from pharmaceutical companies; his time chairing the Conflict of Interest Committee; litigation surrounding the sale of Antilymphocyte Globulin (ALG); the creation of Medication Management Systems, Inc. Dr. Cipolle concludes with a reflection on changing demographics within pharmacy, the changing culture of pharmacy, and the naming of Unit F.
Description
Robert Cipolle earned his bachelor’s degree in pharmacy from the College of Pharmacy at the University of Illinois Medical Center in 1974. While completing his degree, he apprenticed at Rush Presbyterian Saint Luke Medical Center in Chicago. He then earned his Pharm.D. from the University of Minnesota’s College of Pharmacy in 1976. He was an instructor in the College from 1976 to 1978. He became a professor in the College in 1978, while also serving as associate director of Pharmaceutical Services at St. Paul-Ramsey, a position he held until 1984. He became vice chairman of the Department of Pharmacy in the College in 1984 and then associate head of the Department in 1987. From 1988 to 1992, he served as associate dean for Academic Affairs in the College of Pharmacy. He then served as dean of the College from 1992 to 1994. He co-founded the Peters Institute of Pharmaceutical Care in 1995 and served as director for over a decade. In 2006, he co-founded Medication Management Systems, Inc., a University of Minnesota start-up. He retired in 2011.
Related to
Replaces
License
Collections
Series/Report Number
Funding information
Isbn identifier
Doi identifier
Previously Published Citation
Suggested citation
Tobbell, Dominique A.; Cipolle, Robert J.. (2012). Interview with Robert J. Cipolle. Retrieved from the University Digital Conservancy, https://hdl.handle.net/11299/165372.
Content distributed via the University Digital Conservancy may be subject to additional license and use restrictions applied by the depositor. By using these files, users agree to the Terms of Use. Materials in the UDC may contain content that is disturbing and/or harmful. For more information, please see our statement on harmful content in digital repositories.